Our Advisory Team

TOM BRENNAN

FOUNDING INVETSOR AND BOARD MEMBER

  • Tom Brennan co-founded EirGen Pharma in 2005, which was acquired by OPKO Corp in 2015, and Q1 Scientific in 2013, later acquired by Cambrex Corp in 2022. In 2018, he co-founded TriviumVet, further expanding his influence in the healthcare sector. Tom also served as a board member for Crest Solutions, which was acquired by Water Street Capital in 2022, and continues to serve on the board of Cancer Trials Ireland, where he remains an active contributor.

ROLAND TURCK MD

COMMERCIAL ADVISOR

  • Managing Partner of TurckBio, an international consulting firm focused on corporate strategy as well as on clinical and commercial strategies in oncology and other specialty medicine areas.

JOHN H. SAMPSON MD

CLINICAL ADVISOR

  • The Robert H. and Gloria Wilkins Distinguished Professor, inaugural chair of the Department of Neurosurgery at Duke University, and the most highly funded PI in neurosurgery by the NIH.

HOWARD TAG

Market Access Advisor

  • Howard Tag, founder of Tag & Associates, provides pricing, reimbursement and market access advice to medical technology developers and to investment, law and communication firms that serve health care manufacturers.

DR MARK POWELL

CMC Advisor

  • Founder of Mark Powell Scientific Limited to provide technical support for pre-clinical drug development with over 20 years of industry experience.